These contaminated eye drops contain methylsulfonylmethane (MSM), a natural organosulfur compound often utilized in complementary and alternative medicine and now associated with contaminated products.
The US Food and Drug Administration (FDA) has issued a warning regarding the acquisition or utilization of contaminated eye drops from the brands Dr. Berne’s and LightEyez, owing to potential microbial contamination.
According to an article published by ABC 11, the US Food and Drug Administration (FDA) has cautioned against the purchase or use of specific contaminated eye drops from Dr. Berne’s and LightEyez brands due to potential microbial contamination.
These contaminated eye drops contain methylsulfonylmethane (MSM), a natural organosulfur compound frequently used in complementary and alternative medicine. Dr. Berne’s has voluntarily recalled its MSM Drops 5% Solution after tests revealed bacterial and fungal contamination.
On the other hand, LightEyez’s MSM Eye Drops – Eye Repair was found to contain contaminated eye drops with four types of bacteria, but the company has not responded to the FDA’s concerns or requests for a product recall.
READ ALSO: ATM Robbers Trigger Investigation: Clark County Sheriff’s Office Probes Bold Heist in Hazel Dell
The FDA strongly emphasized that these contaminated eye drops are unauthorized drugs and have been marketed illegally in the United States.
According to an article published by Western Mass News, the announcement, issued on a Tuesday, stressed that no legally approved ophthalmic drugs contain MSM as an active ingredient.
Therefore, consumers who possess these contaminated eye drops are advised to dispose of them immediately. The FDA highlighted that using contaminated eye drops could lead to vision-related infections ranging from minor to severe, potentially escalating to life-threatening infections.
Despite no reported adverse events linked to these contaminated eye drops, individuals displaying symptoms of an eye infection are urged to seek prompt medical attention.
The FDA also urged healthcare professionals and consumers to report any adverse events or quality concerns regarding contaminated eye drops through the FDA’s MedWatch program.